Chemotherapy Mucositis Site — MFDS Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Buccal mucosa, floor of mouth, ventrolateral tongue and soft palate
The correct answer is B. Conventional cytotoxic chemotherapy preferentially produces diffuse erythema and ulceration on movable, non-keratinised mucosa, particularly the buccal and labial mucosa, floor of mouth, ventrolateral tongue and soft palate. These rapidly renewing epithelial surfaces are especially susceptible to cytotoxic injury, with symptoms commonly emerging about one week after treatment. The hard palate and attached gingiva in B are predominantly keratinised and are less characteristically affected; ulceration at these sites should raise alternatives such as recurrent intraoral herpes simplex. Option D describes a predominantly periodontal distribution, D a salivary-duct distribution, and E a perioral rather than intraoral mucosal distribution.
Reference: Woo SB, Sonis ST, Sonis AL. The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients. Cancer. 1990;66:2375–2379. https://wmcanceralliance.nhs.uk/images/Documents/SaCT/Network_Guidelines_for_the_Oral_Care_of_Patients_receiving_SACT_v4.pdf